SUBLINGUALE FORMULIERUNG VON RILUZOL

European patent · EP4039247 · In force

Register entry

Publication number
EP4039247
Application number
EP21169884
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 17, 2015
Published
Aug 10, 2022
Granted
Nov 5, 2025
Protection ends at the latest
Nov 16, 2035
Next annual fee due
Nov 30, 2026
IPC classes
A61K 9/00 (2006.01)
A61K 9/08 (2006.01)
A61K 9/20 (2006.01)
A61K 31/428 (2006.01)
A61K 47/20 (2006.01)
A61K 47/26 (2006.01)
A61P 25/00 (2006.01)
A61P 25/16 (2006.01)
A61P 25/18 (2006.01)
A61P 25/22 (2006.01)
A61P 25/24 (2006.01)
A61P 25/28 (2006.01)
A61P 25/30 (2006.01)
Priority
US 201462083094 P 21.11.2014
Divided from
EP19186196
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 16, 2026

    Change

    Published in Swissreg on 16.09.2026

  2. Apr 30, 2026

    Next annual fee due on

    Next annual fee due on
    30.11.2025 → 30.11.2026

    Published in Swissreg on 30.04.2026

  3. Jan 19, 2026

    Agent entered

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 19.01.2026

  4. Nov 5, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 05.11.2025

Parties

Inventor

CORIC, Vladimir

Madison, 06443, US

BERMAN, Robert M.

New Haven, 06511, US

VLADYKA, Ronald Samuel

Somerst, 08873, US

SALEH, Amgad

Dayton, 08810, US

YU, Danny

Somerville, 08876, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.